Xuelin (Steve) Wang
  1. Counsel - Registered Foreign Lawyer

Mr. Wang is counsel in Davis Polk’s Corporate Department, currently practicing as a Registered Foreign Lawyer in Hong Kong. His practice focuses on the areas of securities offerings as well as mergers and acquisitions. Mr. Wang has represented issuers and underwriters in a wide range of international capital markets transactions, including initial public offerings and follow-on equity offerings, investment-grade and high-yield debt offerings, and liability management transactions. He has a Ph.D. in cell biology and frequently works on corporate financing transactions for companies in the pharmaceutical sector.

Work Highlights

Debt Capital Markets

Investment-Grade

  • 22 investment-grade and MTN notes offerings by Hangzhou Hikvision Digital Technology, China Oceanwide International Financial Management, China Orient Asset Management, Asia Standard International, JD.com, Baidu, PPL Corporation, CSX Corporation, Kennametal, China Forestry Group, China Petrochemical, Greenland Hong Kong, Republic of Indonesia, China Cinda Asset Management, Pertamina, Bangkok Bank and AVIC International

High-Yield

  • 30 high-yield notes offerings by Fantasia, Zhenro Properties Group, Shandong Yuhuang Chemical, West China Cement, KWG Property, Guorui Properties, SOCAM Development, China South City, CIFI, PT Cikarang Listrindo, China SCE Property, Sunac China, Times Property, Redco Properties, Central China Real Estate, Evergrande, Fosun International Limited and Dufry AG

Liability Management

  • 8 consent solicitations and tender offers for SOCAM Development, Times Property, Redco Properties, Country Garden, SOHO China, Central China Real Estate, Sunac China and K. Hovnanian Enterprises
Equity Capital Markets
  • CStone Pharmaceuticals' $285 million Hong Kong IPO and global offering
  • Innovent Biologics’ $403.1 million Hong Kong IPO and global offering
  • BeiGene's $903 million Hong Kong IPO and global offering
  • Ping An Healthcare and Technology's $1.12 billion Hong Kong IPO and global offering
  • 3SBio's $712 million Hong Kong IPO and global offering
  • 9F Inc.'s $84.6 million SEC-registered U.S. IPO on Nasdaq
  • DouYu's $775 million SEC-registered U.S. IPO on Nasdaq 
  • Luckin Coffee’s $570 million SEC-registered U.S. IPO on Nasdaq and $50 million private placements
  • Cango Inc.’s $44 million SEC-registered U.S. IPO on NYSE
  • Uxin Limited’s $225 million SEC-registered U.S. IPO on Nasdaq
  • iClick Interactive's $27.5 million SEC-registered U.S. IPO on Nasdaq
  • RISE Education's $171 million SEC-registered U.S. IPO on Nasdaq and $97.2 million follow-on offering
  • Zai Lab Limited’s $172.5 million SEC-registered U.S. IPO on Nasdaq and $150 million follow-on offering
  • Edwards Group's $100 million SEC-registered U.S. IPO on Nasdaq
  • Ronshine’s HK$1.1 billion top-up placement
  • China Maple Leaf Educational System’s HK$1 billion top-up placement
  • Beijing Enterprises Water’s $2.66 billion share placement 
  • Canadian Solar's SEC-registered $100 million at-the-market offering
  • Banco Santander (Brasil)'s SEC-registered secondary at-the-market ADS offering
  • PDC Energy's SEC-registered $172 million equity offering
  • Hovnanian's SEC-registered $47 million equity offering
  • Modern Times Group's Class B shares Section 12(g) registration
M&A
  • Sale of Alliance Tire Group to KKR
  • Sale of Business Process Outsourcing Businesses of Philippine Long Distance Telephone Company to CVC Capital
  • China Hydroelectric Corporation's (NYSE-listed) going-private transaction
  • Sale of Amanresorts to its founders

Professional History

  • Davis Polk since 2011

Bar Admissions

  • State of New York
  • Hong Kong Law Society - Registered

Education

  • B.S., Biology, Nanjing University, 2000
  • Ph.D., Genetics and Cell Biology, University of Minnesota, 2008
  • J.D., University of Minnesota Law School, 2011
    • magna cum laude
    • Order of the Coif
    • Articles Editor, Minnesota Journal of Law, Science & Technology

Languages

  • Mandarin